HER2 Signaling in Breast Cancer Treatment (Q167950)

From geokb
Revision as of 14:10, 24 May 2024 by Sky (talk | contribs) (‎Created a new Item: Added new OpenAlex topic claimed by USGS staff from API)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
This cluster of papers focuses on the use of HER2-targeted therapies, such as trastuzumab and pertuzumab, in the treatment of HER2-positive breast cancer
  • HER2
  • breast cancer
  • trastuzumab
  • EGFR
  • monoclonal antibody
  • chemotherapy
  • metastatic
  • receptor tyrosine kinases
  • neuregulin 1
  • ADAM metalloproteinases
Language Label Description Also known as
English
HER2 Signaling in Breast Cancer Treatment
This cluster of papers focuses on the use of HER2-targeted therapies, such as trastuzumab and pertuzumab, in the treatment of HER2-positive breast cancer
  • HER2
  • breast cancer
  • trastuzumab
  • EGFR
  • monoclonal antibody
  • chemotherapy
  • metastatic
  • receptor tyrosine kinases
  • neuregulin 1
  • ADAM metalloproteinases

Statements